A detailed history of Mascoma Wealth Management LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 710 shares of ABBV stock, worth $120,131. This represents 0.04% of its overall portfolio holdings.

Number of Shares
710
Previous 973 27.03%
Holding current value
$120,131
Previous $166,000 15.66%
% of portfolio
0.04%
Previous 0.04%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$163.84 - $199.33 $43,089 - $52,423
-263 Reduced 27.03%
710 $140,000
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $7,739 - $9,038
50 Added 5.42%
973 $166,000
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $26,718 - $30,930
-200 Reduced 17.81%
923 $137,000
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $38,162 - $47,491
-288 Reduced 20.41%
1,123 $151,000
Q1 2023

May 01, 2023

SELL
$144.61 - $166.54 $28,922 - $33,308
-200 Reduced 12.41%
1,411 $224,000
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $110,648 - $132,696
-800 Reduced 33.18%
1,611 $0
Q3 2022

Oct 18, 2022

BUY
$134.21 - $153.93 $107,368 - $123,144
800 Added 49.66%
2,411 $324,000
Q1 2022

Apr 25, 2022

BUY
$131.98 - $163.75 $7,654 - $9,497
58 Added 3.73%
1,611 $261,000
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $5,371 - $6,796
50 Added 3.33%
1,553 $210,000
Q3 2021

Oct 06, 2021

BUY
$106.4 - $120.78 $159,919 - $181,532
1,503 New
1,503 $162,000
Q2 2021

Jul 06, 2021

SELL
$105.21 - $117.21 $158,130 - $176,166
-1,503 Closed
0 $0
Q1 2021

Apr 26, 2021

BUY
$102.3 - $112.62 $153,756 - $169,267
1,503 New
1,503 $162,000
Q3 2019

Nov 21, 2019

SELL
$62.98 - $75.72 $371,582 - $446,748
-5,900 Closed
0 $0
Q2 2019

Jul 29, 2019

SELL
$65.7 - $83.98 $49,077 - $62,733
-747 Reduced 11.24%
5,900 $429,000
Q1 2019

Apr 23, 2019

SELL
$77.14 - $90.79 $7,482 - $8,806
-97 Reduced 1.44%
6,647 $536,000
Q4 2018

Jan 28, 2019

BUY
$77.85 - $96.01 $11,833 - $14,593
152 Added 2.31%
6,744 $622,000
Q3 2018

Nov 08, 2018

BUY
$88.91 - $98.84 $187,866 - $208,848
2,113 Added 47.18%
6,592 $623,000
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $296,453 - $350,771
3,302 Added 280.54%
4,479 $415,000
Q1 2018

Apr 24, 2018

SELL
$92.01 - $123.21 $9,016 - $12,074
-98 Reduced 7.69%
1,177 $111,000
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $763,319 - $837,043
-8,523 Reduced 86.99%
1,275 $147,000
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $684,390 - $874,177
9,798
9,798 $871,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $299B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mascoma Wealth Management LLC Portfolio

Follow Mascoma Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.